Chronic Kidney Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Chronic Kidney Disease stocks.

Chronic Kidney Disease Stocks Recent News

Date Stock Title
Nov 21 AZN AstraZeneca's Andexxa Faces FDA Scrutiny Over Effectiveness, Safety Concerns
Nov 21 AZN We Think AstraZeneca's (LON:AZN) Healthy Earnings Might Be Conservative
Nov 21 AZN 3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now
Nov 21 AZN AstraZeneca upgraded to Neutral from Sell at UBS
Nov 21 AZN AstraZeneca price target lowered to EUR 140 from EUR 150 at Berenberg
Nov 20 AKBA Q3 2024 Earnings: Hold Akebia Therapeutics
Nov 20 SNY CDC warns of an imminent spike in COVID, flu cases
Nov 20 SNY Here’s What Drove Sanofi’s (SNY) Earnings
Nov 20 AZN AstraZeneca raised to neutral at UBS despite China headwinds
Nov 20 SNY Sanofi: Information concerning the total number of voting rights and shares - October 2024
Nov 20 ARDX Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference
Nov 20 AZN AstraZeneca awards $3.5M for projects to improve access to healthcare for patients across the US
Nov 20 AZN Daiichi Sankyo and AstraZeneca’s Enhertu snubbed by UK’s NICE for third time
Nov 20 AZN AstraZeneca Is No Longer a Sell for Any Analyst as UBS Upgrades
Nov 20 AZN FTSE 100 and European-listed stocks to own in 2025, according to Barclays
Nov 19 ARDX High Growth Tech Stocks To Explore In November 2024
Nov 19 LSTA Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’
Nov 19 AZN CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC
Nov 19 AZN AstraZeneca’s Tagrisso recommended for approval in EU by CHMP for certain NSCLC
Nov 19 AZN CHMP recommends AstraZeneca’s Tagrisso for EU approval for NSCLC
Chronic Kidney Disease

Chronic kidney disease (CKD) is a type of kidney disease in which there is gradual loss of kidney function over a period of months or years. Early on there are typically no symptoms. Later, leg swelling, feeling tired, vomiting, loss of appetite, or confusion may develop. Complications may include heart disease, high blood pressure, bone disease, or anemia.Causes of chronic kidney disease include diabetes, high blood pressure, glomerulonephritis, and polycystic kidney disease. Risk factors include a family history of the condition. Diagnosis is generally by blood tests to measure the glomerular filtration rate and urine tests to measure albumin. Further tests such as an ultrasound or kidney biopsy may be done to determine the underlying cause. A number of different classification systems exist.Screening at-risk people is recommended. Initial treatments may include medications to manage blood pressure, blood sugar, and lower cholesterol. NSAIDs should be avoided. Other recommended measures include staying active and certain dietary changes. Severe disease may require hemodialysis, peritoneal dialysis, or a kidney transplant. Treatments for anemia and bone disease may also be required.Chronic kidney disease affected 753 million people globally in 2016, including 417 million females and 336 million males. In 2015 it resulted in 1.2 million deaths, up from 409,000 in 1990. The causes that contribute to the greatest number of deaths are high blood pressure at 550,000, followed by diabetes at 418,000, and glomerulonephritis at 238,000.

Browse All Tags